Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts.
J Infect Dis. 2014 Feb 1;209(3):345-9. doi: 10.1093/infdis/jit437. Epub 2013 Aug 14.
We investigated thymidine kinase (tk) mutants isolated during multiple episodes of recurrent bilateral acyclovir resistant herpes simplex keratitis in an immunocompetent patient. From one eye, we found a single guanine insertion, previously shown to greatly reduce TK expression, and from the other, a previously unidentified substitution, which genetic experiments confirmed confers drug resistance. The substitution, although distant from substrate binding sites, reduced thymidine phosphorylation 10-20-fold, and acyclovir phosphorylation >100-fold. This phenotype should permit reactivation from latency to cause recurrent disease. The results may have implications for the prevalence and prevention of acyclovir resistance in patients with herpes simplex keratitis.
我们研究了一位免疫功能正常的患者反复发作的双侧阿昔洛韦耐药性单纯疱疹角膜炎中分离出的胸苷激酶(tk)突变体。从一只眼我们发现了一个单一的鸟嘌呤插入,先前的研究表明它极大地降低了 TK 的表达,而另一只眼则发现了一个以前未识别的替代物,遗传实验证实该替代物赋予了药物耐药性。该替代物虽然远离底物结合位点,但使胸苷磷酸化降低了 10-20 倍,而阿昔洛韦磷酸化则提高了 100 倍以上。这种表型可能会导致潜伏性再激活,从而导致疾病反复发作。这些结果可能对单纯疱疹角膜炎患者阿昔洛韦耐药的流行和预防具有重要意义。